Clinical Trial Update: Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19 [NA]

View source ↗

Summary

This clinical trial update indicates that the study of olfactory disorders in patients with persistent loss of smell after COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Olfactory Dysfunction

Snippet

Sponsor: Institut Pasteur | Conditions: SARS-CoV-2 Acute Respiratory Disease | NA | Status: COMPLETED